PLX
Protalix Biotherapeutics Inc
2.80$
-1.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 82.9% | 82.8% | 83.9% | 84.5% | 77.7% | 81.8% | 81.9% | 83.4% | 80.8% | 81.0% | 84.4% | 83.6% | |
| 23.3% | 28.0% | 30.3% | 25.6% | 44.5% | 26.9% | 26.3% | 22.8% | 16.6% | 17.8% | 40.8% | 24.9% | |
| 46.8% | 52.8% | 54.0% | 49.2% | 44.5% | 47.4% | 47.0% | 42.6% | 35.7% | 36.8% | 50.6% | 36.8% | |
| 10.2% | 6.2% | 4.2% | 11.1% | 3.6% | 4.0% | 6.3% | 12.0% | 17.5% | 10.7% | 2.9% | 15.0% | |
| 24.6% | 22.6% | 24.9% | 22.6% | 27.9% | 28.9% | 26.4% | 26.9% | 25.8% | 31.2% | 29.8% | 29.3% | |
| 12.1% | – | – | – | 16.7% | 13.6% | 13.5% | 12.4% | 15.2% | 15.3% | – | – | |
| 56.3% | 60.2% | 66.8% | 68.8% | 47.3% | 41.1% | 38.8% | 36.4% | 35.7% | 41.4% | 34.3% | 35.3% | |
| 49.5% | 53.9% | 61.0% | 63.3% | 39.3% | 34.9% | 32.9% | 30.7% | 26.7% | 32.2% | 26.8% | 28.5% | |
| 24.6% | 25.7% | 24.4% | 25.5% | 2.4% | 2.0% | 1.9% | 1.9% | 1.7% | 1.7% | 1.4% | 1.5% | |
| 3.6% | 5.1% | 3.5% | 4.4% | 5.1% | 6.2% | 5.6% | 8.5% | 6.5% | 6.4% | 4.2% | 5.9% | |
| 43.7% | 39.8% | 33.2% | 31.2% | 52.7% | 58.9% | 61.2% | 63.6% | 64.3% | 58.6% | 65.7% | 64.7% | |
| -428.8% | -451.9% | -429.6% | -424.0% | -625.2% | -515.4% | -517.0% | -486.5% | -461.3% | -467.5% | -358.3% | -328.9% | |
| 95.7% | 86.4% | 81.3% | 80.1% | 131.9% | 110.4% | 103.7% | 103.5% | 98.2% | 95.4% | 81.2% | 74.8% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.